Pruduct Name:
Microcapsuled Enrofloxacin(10%)
Trade Name:
Neo-enfx
Trademark:
Marketing Status: Rx
Key Component:
enrofloxacin micropowder (10%);
Specific plant-based lipidic coating.
Description:
White granule (60±20 mesh)
Production Methods:
Intelligent Microcapsule Technology (IM)
Features:
acid & alkali resistant
and hydrophobic
Never bitter or irritant in mouth / stomach
Sustained released in the small intestine
Well mixed with feed because of rough surface
Lightproof coating and box avoiding
photolysis
Pharmacological Action:
Just like enrofloxacin powder, Neo-enfx has antibacterial activity against a broad spectrum of
gram-negative
and
gram-positive
bacteria as follows:
Pseudomonas aeruginosa
,
Klebsiella spp.
,
Escherichia coli
,
Enterobacter
,
Campylobacter
,
Shigella
,
Salmonella
,
Aeromonas
,
Haemophilus
,
Proteus
,
Yersinia
,
Serratia
,
Vibrio
,
Brucella
,
Chlamydia trachomatis
,
Mycoplasma
,
Mycobacterium sp
.,
Staphylococci
(including penicillinase-producing and methicillin-resistant strains)
Variable activity against:
streptococci
Ineffective against anaerobes
Adverse Reaction:
No prescription
Indication:
Enrofloxacin Premix. Used to prevent and treat respiratory diseases, septic colibacillosis, malignant rhinitis, pasteurella, salmonellosis, staphylocosis, dysentery, endemic epidemic pneumonia, hydropsy, mastitis and so on.
Usage and Dosage: (eg. pig):
Prevention: 0.80~1.0 g/kg feed
Treatment: 1.0~1.5 g/kg feed
Using for 5 - 7 continuous days
Precaution:
Do not recommend long-term overuse in piglet to avoid potential cartilage abnormality.
Withdrawal Period:
7 days before the slaughter
Content Specification:
100g: 10g
Packing:
10kg
St orage: Sealed in cool and dry place
Validity:
24 months
Whatsapp
